Nakane, K.; Watanabe, H.; Naiki, T.; Takahara, K.; Yasui, T.; Miyake, H.; Shiroki, R.; Koie, T.
Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence. Diagnostics 2023, 13, 1661.
https://doi.org/10.3390/diagnostics13091661
AMA Style
Nakane K, Watanabe H, Naiki T, Takahara K, Yasui T, Miyake H, Shiroki R, Koie T.
Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence. Diagnostics. 2023; 13(9):1661.
https://doi.org/10.3390/diagnostics13091661
Chicago/Turabian Style
Nakane, Keita, Hiromitsu Watanabe, Taku Naiki, Kiyoshi Takahara, Takahiro Yasui, Hideaki Miyake, Ryoichi Shiroki, and Takuya Koie.
2023. "Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence" Diagnostics 13, no. 9: 1661.
https://doi.org/10.3390/diagnostics13091661
APA Style
Nakane, K., Watanabe, H., Naiki, T., Takahara, K., Yasui, T., Miyake, H., Shiroki, R., & Koie, T.
(2023). Trends in the Use of Second-Generation Androgen Receptor Axis Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer and Clinical Factors Predicting Biological Recurrence. Diagnostics, 13(9), 1661.
https://doi.org/10.3390/diagnostics13091661
